SEC Form 4 · accession 0001437749-16-041579
Oxford Immunotec Global PLC · OXFD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard A Sandberg
Director
Period of report
Nov 8, 2016
Accepted (ET)
Nov 9, 2016 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001586049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ORDINARY SHARES | Nov 8, 2016 | S | 400 | $14.185 | D | 31,774 | D | |
| ORDINARY SHARES | Nov 8, 2016 | S | 1,500 | $14.17 | D | 30,274 | D | |
| ORDINARY SHARES | Nov 8, 2016 | S | 400 | $14.20 | D | 29,874 | D | |
| ORDINARY SHARES | Nov 8, 2016 | S | 200 | $14.15 | D | 29,674 | D | |
| ORDINARY SHARES | Nov 8, 2016 | S | 9,500 | $14.165 | D | 20,174 | D |
Table II — derivative securities
No Table II lines on this filing.